SCHEMBL19212007

SCHEMBL19212007

CCC(C(P(=O)(O)O)P(=O)(O)O)P(=O)(O)O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LAP3 P28838 1/20 0.46
FDPS P14324 8/20 0.40
METAP1 P53582 2/20 0.34
MMP2 P08253 2/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
MMP1 P03956 1/20 0.34
MMP8 P22894 1/20 0.34
CA9 Q16790 1/20 0.34
LPAR3 Q9UBY5 2/20 0.33
KDM4E B2RXH2 1/20 0.33
THRB P10828 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
LPAR2 Q9HBW0 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19212081 0.82 LAP3 (0.41) LAP3FDPSMETAP1MMP2MMP1
SCHEMBL8015730 0.78 LAP3 (0.46) LAP3FDPSMETAP1MMP2MMP1
SCHEMBL19212095 0.77 KDM4E (0.37) LAP3FDPSMMP2CA2KDM4E
SCHEMBL28539152 0.76 LAP3 (0.44) LAP3FDPSMETAP1MMP2MMP1
SCHEMBL16797954 0.76 LAP3 (0.44) LAP3FDPSMETAP1MMP2MMP1
SCHEMBL250731 0.74 GABBR2 (0.40) MMP2KDM4ETHRBMAPK1HSD17B10
SCHEMBL6227459 0.74 LAP3 (0.54) LAP3FDPSMETAP1ALDH1A1
SCHEMBL2850492 0.74 LAP3 (0.54) LAP3FDPSMETAP1ALDH1A1
SCHEMBL30585641 0.74 LAP3 (0.42) LAP3FDPSMETAP1MMP2MMP1
SCHEMBL19212003 0.74 LAP3 (0.42) LAP3FDPSMETAP1MMP2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3413934-B1 IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS NANO BRIDGING MOLECULES SA (CH) 2021-10-13 EP claimed
CN-109195641-B Improved implant treatment with phosphonic acid compounds 纳米桥接分子股份公司 2021-07-27 CN claimed
US-11000627-B2 Treatment of implants with phosphonic acid compounds NANO BRIDGING MOLECULES SA (CH) 2021-05-11 US claimed
US-20190038802-A1 IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS NANO BRIDGING MOLECULES SA (CH) 2019-02-07 US claimed
EP-3413934-B1 IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS NANO BRIDGING MOLECULES SA (CH) 2021-10-13 EP disclosed
CN-109195641-B Improved implant treatment with phosphonic acid compounds 纳米桥接分子股份公司 2021-07-27 CN disclosed
US-11000627-B2 Treatment of implants with phosphonic acid compounds NANO BRIDGING MOLECULES SA (CH) 2021-05-11 US disclosed
US-20190038802-A1 IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS NANO BRIDGING MOLECULES SA (CH) 2019-02-07 US disclosed
EP-3413934-A1 IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS Nano Bridging Molecules SA (CH) 2018-12-19 EP disclosed
WO-2017137623-A1 IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS NANO BRIDGING MOLECULES SA (CH) 2017-08-17 WO disclosed